NPR1 promotes cisplatin resistance by inhibiting PARL-mediated mitophagy-dependent ferroptosis in gastric cancer.


Journal

Cell biology and toxicology
ISSN: 1573-6822
Titre abrégé: Cell Biol Toxicol
Pays: Switzerland
ID NLM: 8506639

Informations de publication

Date de publication:
30 Oct 2024
Historique:
received: 09 04 2024
accepted: 16 10 2024
medline: 31 10 2024
pubmed: 30 10 2024
entrez: 30 10 2024
Statut: epublish

Résumé

Cisplatin-based chemotherapy serves as the standard of care for individuals with advanced stages of gastric cancer. Nevertheless, the emergence of chemoresistance in GC has detrimental impacts on prognosis, yet the underlying mechanisms governing this phenomenon remain elusive. Level of mitophagy and ferroptosis of GC cells were detected by fluorescence, flow cytometry, GSH, MDA, Fe

Identifiants

pubmed: 39476297
doi: 10.1007/s10565-024-09931-z
pii: 10.1007/s10565-024-09931-z
doi:

Substances chimiques

Cisplatin Q20Q21Q62J
Antineoplastic Agents 0
Receptors, Atrial Natriuretic Factor EC 4.6.1.2

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

93

Subventions

Organisme : Anhui Provincial Health Commission Provincial Financial Key Projects
ID : AHWJ2023A10126
Organisme : Natural Science Research Project of Higher Education in Anhui Province
ID : KJ2021A0857
Organisme : Natural Science Research Project of Higher Education in Anhui Province
ID : 2023AH051771
Organisme : Natural Science Foundation of China
ID : 82372707

Informations de copyright

© 2024. The Author(s).

Références

Ajani JA, et al. Gastric Cancer, Version 2.2022, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2022;20:167–92. https://doi.org/10.6004/jnccn.2022.0008 .
doi: 10.6004/jnccn.2022.0008 pubmed: 35130500
Cao T, et al. NPRA promotes fatty acid metabolism and proliferation of gastric cancer cells by binding to PPARα. Transl Oncol. 2023;35:101734. https://doi.org/10.1016/j.tranon.2023.101734 .
doi: 10.1016/j.tranon.2023.101734 pubmed: 37418841
Chen X, Kang R, Kroemer G, Tang D. Broadening horizons: the role of ferroptosis in cancer. Nat Rev Clin Oncol. 2021;18:280–96. https://doi.org/10.1038/s41571-020-00462-0 .
doi: 10.1038/s41571-020-00462-0 pubmed: 33514910
Chen Z, et al. MSC-NPRA loop drives fatty acid oxidation to promote stemness and chemoresistance of gastric cancer. Cancer Lett. 2023;565:216235. https://doi.org/10.1016/j.canlet.2023.216235 .
doi: 10.1016/j.canlet.2023.216235 pubmed: 37209945
Dai E, et al. Autophagy-dependent ferroptosis drives tumor-associated macrophage polarization via release and uptake of oncogenic KRAS protein. Autophagy. 2020;16:2069–83. https://doi.org/10.1080/15548627.2020.1714209 .
doi: 10.1080/15548627.2020.1714209 pubmed: 31920150
Gao Y, et al. Self-amplified ROS production from fatty acid oxidation enhanced tumor immunotherapy by atorvastatin/PD-L1 siRNA lipopeptide nanoplexes. Biomaterials. 2022;291:121902. https://doi.org/10.1016/j.biomaterials.2022.121902 .
doi: 10.1016/j.biomaterials.2022.121902 pubmed: 36371945
Guan WL, He Y, Xu RH. Gastric cancer treatment: recent progress and future perspectives. J Hematol Oncol. 2023;16:57. https://doi.org/10.1186/s13045-023-01451-3 .
doi: 10.1186/s13045-023-01451-3 pubmed: 37245017
Jiang X, Stockwell BR, Conrad M. Ferroptosis: mechanisms, biology and role in disease. Nat Rev Mol Cell Biol. 2021;22:266–82. https://doi.org/10.1038/s41580-020-00324-8 .
doi: 10.1038/s41580-020-00324-8 pubmed: 33495651 pmcid: 8142022
Lee S, et al. Autophagy mediates an amplification loop during ferroptosis. Cell Death Dis. 2023;14:464. https://doi.org/10.1038/s41419-023-05978-8 .
doi: 10.1038/s41419-023-05978-8 pubmed: 37491375
Li Z, et al. Natriuretic peptide receptor A inhibition suppresses gastric cancer development through reactive oxygen species-mediated G2/M cell cycle arrest and cell death. Free Radic Biol Med. 2016;99:593–607. https://doi.org/10.1016/j.freeradbiomed.2016.08.019 .
doi: 10.1016/j.freeradbiomed.2016.08.019 pubmed: 27634171
Li Z, et al. Natriuretic peptide receptor a promotes gastric malignancy through angiogenesis process. Cell Death Dis. 2021;12:968. https://doi.org/10.1038/s41419-021-04266-7 .
doi: 10.1038/s41419-021-04266-7 pubmed: 34671022
Li J, et al. The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks. Int J Biol Sci. 2023;19:2756–71. https://doi.org/10.7150/ijbs.83348 .
doi: 10.7150/ijbs.83348 pubmed: 37324946
Lin Q, et al. Mitophagy alleviates cisplatin-induced renal tubular epithelial cell ferroptosis through ROS/HO-1/GPX4 axis. Int J Biol Sci. 2023;19:1192–210. https://doi.org/10.7150/ijbs.80775 .
doi: 10.7150/ijbs.80775 pubmed: 36923942
Liu M, et al. Ferroptosis inducer erastin sensitizes NSCLC cells to celastrol through activation of the ROS-mitochondrial fission-mitophagy axis. Mol Oncol. 2021;15:2084–105. https://doi.org/10.1002/1878-0261.12936 .
doi: 10.1002/1878-0261.12936 pubmed: 33675143
López MJ, et al. Characteristics of gastric cancer around the world. Crit Rev Oncol Hematol. 2023;181:103841. https://doi.org/10.1016/j.critrevonc.2022.103841 .
doi: 10.1016/j.critrevonc.2022.103841 pubmed: 36240980
Lugones Y, Loren P, Salazar LA. Cisplatin Resistance: Genetic and Epigenetic Factors Involved. Biomolecules. 2022;12. https://doi.org/10.3390/biom12101365
Lysyk L, Brassard R, Touret N, Lemieux MJ. PARL Protease: A Glimpse at Intramembrane Proteolysis in the Inner Mitochondrial Membrane. J Mol Biol. 2020;432:5052–62. https://doi.org/10.1016/j.jmb.2020.04.006 .
doi: 10.1016/j.jmb.2020.04.006 pubmed: 32320686
Park E, Chung SW. ROS-mediated autophagy increases intracellular iron levels and ferroptosis by ferritin and transferrin receptor regulation. Cell Death Dis. 2019;10:822. https://doi.org/10.1038/s41419-019-2064-5 .
doi: 10.1038/s41419-019-2064-5 pubmed: 31659150
Picca A, Faitg J, Auwerx J, Ferrucci L, D’Amico D. Mitophagy in human health, ageing and disease. Nat Metab. 2023;5:2047–61. https://doi.org/10.1038/s42255-023-00930-8 .
doi: 10.1038/s42255-023-00930-8 pubmed: 38036770
Qin C, et al. STOML2 restricts mitophagy and increases chemosensitivity in pancreatic cancer through stabilizing PARL-induced PINK1 degradation. Cell Death Dis. 2023;14:191. https://doi.org/10.1038/s41419-023-05711-5 .
doi: 10.1038/s41419-023-05711-5 pubmed: 36906621
Radaelli E et al. Mitochondrial defects caused by PARL deficiency lead to arrested spermatogenesis and ferroptosis. Elife. 2023;12. https://doi.org/10.7554/eLife.84710
Su L, Zhang J, Gomez H, Kellum JA, Peng Z. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2023;19:401–14. https://doi.org/10.1080/15548627.2022.2084862 .
doi: 10.1080/15548627.2022.2084862 pubmed: 35678504
Wang Q, et al. JWA regulates TRAIL-induced apoptosis via MARCH8-mediated DR4 ubiquitination in cisplatin-resistant gastric cancer cells. Oncogenesis. 2017;6:e353. https://doi.org/10.1038/oncsis.2017.57 .
doi: 10.1038/oncsis.2017.57 pubmed: 28671676 pmcid: 5541709
Wu Q, et al. NEDD4L inhibits migration, invasion, cisplatin resistance and promotes apoptosis of bladder cancer cells by inactivating the p62/Keap1/Nrf2 pathway. Environ Toxicol. 2023;38:1678–89. https://doi.org/10.1002/tox.23796 .
doi: 10.1002/tox.23796 pubmed: 37087754
Zeng S, et al. Inhibition of Fatty Acid Translocase (FAT/CD36) Palmitoylation Enhances Hepatic Fatty Acid β-Oxidation by Increasing Its Localization to Mitochondria and Interaction with Long-Chain Acyl-CoA Synthetase 1. Antioxid Redox Signal. 2022;36:1081–100. https://doi.org/10.1089/ars.2021.0157 .
doi: 10.1089/ars.2021.0157 pubmed: 35044230
Zhang C, Liu X, Jin S, Chen Y, Guo R. Ferroptosis in cancer therapy: a novel approach to reversing drug resistance. Mol Cancer. 2022;21:47. https://doi.org/10.1186/s12943-022-01530-y .
doi: 10.1186/s12943-022-01530-y pubmed: 35151318 pmcid: 8840702
Zhao L, et al. Ferroptosis in cancer and cancer immunotherapy. Cancer Commun (Lond). 2022;42:88–116. https://doi.org/10.1002/cac2.12250 .
doi: 10.1002/cac2.12250 pubmed: 35133083 pmcid: 8822596
Zhou B, et al. Ferroptosis is a type of autophagy-dependent cell death. Semin Cancer Biol. 2020;66:89–100. https://doi.org/10.1016/j.semcancer.2019.03.002 .
doi: 10.1016/j.semcancer.2019.03.002 pubmed: 30880243

Auteurs

Chengwei Wu (C)

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, No.2, Zheshan West Road, Wuhu, 241001, Anhui, China.
Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China.

Song Wang (S)

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, No.2, Zheshan West Road, Wuhu, 241001, Anhui, China.
Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China.

Tao Huang (T)

Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China.
Department of Thoracic Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.

Xinran Xi (X)

Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China.

Lishuai Xu (L)

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, No.2, Zheshan West Road, Wuhu, 241001, Anhui, China.
Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China.

Jiawei Wang (J)

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, No.2, Zheshan West Road, Wuhu, 241001, Anhui, China.
Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China.

Yinfen Hou (Y)

Department of Medical Examination Center, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, Wuhu, Anhui, China.

Yabin Xia (Y)

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, No.2, Zheshan West Road, Wuhu, 241001, Anhui, China.
Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China.

Li Xu (L)

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, No.2, Zheshan West Road, Wuhu, 241001, Anhui, China.
Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China.

Luman Wang (L)

Department of Immunology, School of Basic Medical Sciences, Fudan University, Shanghai, China.

Xiaoxu Huang (X)

Department of Gastrointestinal Surgery, The First Affiliated Hospital, Yijishan Hospital of Wannan Medical College, No.2, Zheshan West Road, Wuhu, 241001, Anhui, China. xiaoxuhuang1984@163.com.
Anhui Province Key Laboratory of Non-Coding RNA Basic and Clinical Transformation, Wuhu, Anhui, China. xiaoxuhuang1984@163.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH